Ratings by Craig-Hallum (Adam Vogel)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/23/2026 | MapLight Therapeutics | MPLT | Maintain | Buy (N/A) |
|
Details | ||
| 6/22/2026 | Apogee Therapeutics Inc | APGE | Downgrade | Hold (Buy) |
90.38 (132.91) |
47.06% | Details | |
| 6/16/2026 | PepGen Inc. | PEPG | New Coverage | Buy (N/A) |
1.53 (1.80) |
17.65% | Details | |
| 5/21/2026 | MapLight Therapeutics | MPLT | New Coverage | Buy (N/A) |
27.81 (30.30) |
8.95% | Details | |
| 4/10/2026 | LB Pharmaceuticals Inc | LBRX | New Coverage | Buy (N/A) |
26.29 (31.55) |
20.01% | Details | |
| 3/4/2026 | Immunome Inc. | IMNM | Maintain | Buy (N/A) |
|
Details | ||
| 1/30/2026 | Aclaris Therapeutis | ACRS | New Coverage | Buy (N/A) |
3.43 (4.85) |
41.4% | Details | |
| 1/7/2026 | Apogee Therapeutics Inc | APGE | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2025 | Immunome Inc. | IMNM | Maintain | Buy (N/A) |
|
Details | ||
| 12/3/2025 | Design Therapeutics Inc | DSGN | New Coverage | Buy (N/A) |
8.94 (14.39) |
60.96% | Details | |
| 11/3/2025 | Apogee Therapeutics Inc | APGE | New Coverage | Buy (N/A) |
56.59 (132.91) |
134.86% | Details | |
| 9/5/2025 | Immunome Inc. | IMNM | New Coverage | Buy (N/A) |
9.80 (19.66) |
100.61% | Details |
